Atlas Venture Opportunity Fund Ii, L.p. - Net Worth and Insider Trading
Atlas Venture Opportunity Fund Ii, L.p. Net Worth
The estimated net worth of Atlas Venture Opportunity Fund Ii, L.p. is at least $10 Million dollars as of 2024-05-28. Atlas Venture Opportunity Fund Ii, L.p. is the 10% Owner of Korro Bio Inc and owns about 195,074 shares of Korro Bio Inc (KRRO) stock worth over $10 Million. Details can be seen in Atlas Venture Opportunity Fund Ii, L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Atlas Venture Opportunity Fund Ii, L.p. has not made any transactions after 2024-04-22 and currently still holds the listed stock(s).
Transaction Summary of Atlas Venture Opportunity Fund Ii, L.p.
Atlas Venture Opportunity Fund Ii, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Atlas Venture Opportunity Fund Ii, L.p. owns 4 companies in total, including Day One Biopharmaceuticals Inc (DAWN) , Disc Medicine Inc (IRON) , and Dyne Therapeutics Inc (DYN) among others .
Insider Ownership Summary of Atlas Venture Opportunity Fund Ii, L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| DAWN | Day One Biopharmaceuticals Inc | 2022-06-17 | 10 percent owner |
| IRON | Disc Medicine Inc | 2022-12-29 | 10 percent owner |
| DYN | Dyne Therapeutics Inc | 2022-12-12 | 10 percent owner |
 | | 2024-04-22 | 10 percent owner |
Atlas Venture Opportunity Fund Ii, L.p. Latest Holdings Summary
Atlas Venture Opportunity Fund Ii, L.p. currently owns a total of 1 stock. Atlas Venture Opportunity Fund Ii, L.p. owns 195,074 shares of Korro Bio Inc (KRRO) as of April 22, 2024, with a value of $10 Million.
Latest Holdings of Atlas Venture Opportunity Fund Ii, L.p.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| KRRO | Korro Bio Inc | 2024-04-22 | 195,074 | 48.85 | 9,529,365 |
Holding Weightings of Atlas Venture Opportunity Fund Ii, L.p.
Atlas Venture Opportunity Fund Ii, L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, Atlas Venture Opportunity Fund Ii, L.p. has made a total of 1 transactions in Korro Bio Inc (KRRO) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Korro Bio Inc is the acquisition of 17,857 shares on April 22, 2024, which cost Atlas Venture Opportunity Fund Ii, L.p. around $999,992.
Insider Trading History of Atlas Venture Opportunity Fund Ii, L.p.
- 1
Atlas Venture Opportunity Fund Ii, L.p. Trading Performance
GuruFocus tracks the stock performance after each of Atlas Venture Opportunity Fund Ii, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Atlas Venture Opportunity Fund Ii, L.p. is %. GuruFocus also compares Atlas Venture Opportunity Fund Ii, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Atlas Venture Opportunity Fund Ii, L.p. within 3 months outperforms times out of transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Atlas Venture Opportunity Fund Ii, L.p.'s insider trading performs compared to the benchmark.
Performance of Atlas Venture Opportunity Fund Ii, L.p.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -26.59 | | | | | |
| Relative Return to S&P 500(%) | -32.51 | | | | | |
Atlas Venture Opportunity Fund Ii, L.p. Ownership Network
Atlas Venture Opportunity Fund Ii, L.p. Owned Company Details
What does Day One Biopharmaceuticals Inc do?
Who are the key executives at Day One Biopharmaceuticals Inc?
Atlas Venture Opportunity Fund Ii, L.p. is the 10 percent owner of Day One Biopharmaceuticals Inc. Other key executives at Day One Biopharmaceuticals Inc include Chief Medical Officer Samuel C. Blackman , COO & CFO and Secretary York Charles N Ii , and director & Chief Executive Officer Jeremy Bender .
Day One Biopharmaceuticals Inc (DAWN) Insider Trades Summary
Over the past 18 months, Atlas Venture Opportunity Fund Ii, L.p. made no insider transaction in Day One Biopharmaceuticals Inc (DAWN). Other recent insider transactions involving Day One Biopharmaceuticals Inc (DAWN) include a net sale of 128,497 shares made by Samuel C. Blackman , a net sale of 144,428 shares made by Jeremy Bender , and a net sale of 98,942 shares made by York Charles N Ii .
In summary, during the past 3 months, insiders sold 215,740 shares of Day One Biopharmaceuticals Inc (DAWN) in total and bought 0 shares, with a net sale of 215,740 shares. During the past 18 months, 473,033 shares of Day One Biopharmaceuticals Inc (DAWN) were sold and 2,244,684 shares were bought by its insiders, resulting in a net purchase of 1,771,651 shares.
Day One Biopharmaceuticals Inc (DAWN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Day One Biopharmaceuticals Inc Insider Transactions
Atlas Venture Opportunity Fund Ii, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Atlas Venture Opportunity Fund Ii, L.p.. You might contact Atlas Venture Opportunity Fund Ii, L.p. via mailing address: 300 Technology Square, 8th Floor, Cambridge Ma 02139.
Discussions on Atlas Venture Opportunity Fund Ii, L.p.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
